The State Medicines Control Agency (SMCA) is a governmental body of the Republic of Lithuania with headquarters in Vilnius. Its main responsibility is the protection of public health, through the evaluation and supervision of medicines for human use.
The safety of medicines is monitored constantly by the SMCA through a pharmacovigilance network. The SMCA is involved in working groups of Ministry of Health of Lithuania as well as in scientific and regulatory bodies of European Union including Committees and working parties of European Medicines Agency (EMEA), European Commission, and European Council.
Contact:
Address: Žirmūnų g. 139A, Vilnius 09120. Lithuania
Tel. +370 5 263 9264
Website: http://www.vvkt.lt
Martynas Jocys, Baltics marketing director and Lithuania general manager at AstraZeneca, talks about the role that innovation has played in the company’s strategy, the need for increased patient access in…
Kestutis Liauba, managing director at B Braun in Lithuania, discusses the evolution of the medical devices sector in the country since the opening of the company’s affiliate back in 1996…
Janis Kalejs, country manager Baltics at Mylan, discloses the strategies he has used to successfully lead his affiliate through corporate changes and explains how Mylan aims to continue providing affordable…
Raimundas Voishka, country manager Lithuania and Belarus at Pfizer, highlights the increasing openness of the Baltic region towards innovation and stresses the commitment of Pfizer to bringing innovative as well…
Marius Giedraitis, director and founder of Balux, explains the company’s commitment to shipping high-value temperature-sensitive pharmaceuticals with quality goals of 99.5 percent of deliveries without any deviation by 2019. Could…
Kristina Garuoliene, vice minister at the Ministry of Health of the Republic of Lithuania, explains the cornerstones behind the new National Drug Policy approved in August 2017, the commitment of…
Leonas Kalėtinas, executive director at the Lithuanian Innovative Pharmaceutical Industry Association (IFPA), explains the main dynamics impacting the innovative pharmaceutical industry in the country as well as some initiatives developed…
Šarūnas Narbutas, president at the Lithuanian Cancer Patients’ Coalition (POLA), explains the role of patients in shaping the Lithuanian healthcare system as well as the importance of having an integral…
Rytis Naginevičius, director at software development and market analysis specialist SoftDent discusses the company’s targeted solutions for the pharmaceutical and medical industries. You have a quite unusual profile with no…
Audrius Tutlys, country manager at Teva Lithuania, highlights the importance of Teva in Lithuania, based not only on its broad product offering but also its manufacturing capabilities and shares his…
Mantas Katinas, general manager at Invest Lithuania, discusses the country’s strengths, how it can become an attractive destination for Foreign Direct Investment (FDI) and the commitment of the agency towards…
Marijus Valatka, general manager Lithuania, Latvia and Estonia at Novo Nordisk, explains the current challenges and areas for improvement in diabetes treatment in Lithuania and stresses the company’s commitment to…
See our Cookie Privacy Policy Here
